Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
about
Symptomatic reflux disease: the present, the past and the future.Cardiovascular risk associated with high sodium-containing drugs: A systematic review.Republished: symptomatic reflux disease: the present, the past and the future.Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover studyVolume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects.Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.Role of vitamin D3 combined to alginates in preventing acid and oxidative injury in cultured gastric epithelial cells.The Proton Pump Inhibitor Non-Responder: A Clinical ConundrumManagement of the Acid Pocket.Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in ChinaMedical Treatment of Gastroesophageal Reflux Disease.Between GERD and NERD: the relevance of weakly acidic reflux.Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature?Re‐evaluation of alginic acid and its sodium, potassium, ammonium and calcium salts (E 400–E 404) as food additivesRandomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor.Hepatocyte Transplantation.Alginate: Current Use and Future Perspectives in Pharmaceutical and Biomedical Applications
P2860
Q33834731-AC8D3287-8C3B-42A2-8FD2-338D7F84D3EAQ33880719-853CA260-BDDF-4916-9B0C-8EF180AECA0FQ35048270-02E1DD79-9EB9-40FA-9867-AF7093465547Q35129666-CE6F50EC-8E62-4932-B2F3-800F8C31CA35Q35761321-B930A965-0995-418F-9322-DAF66C46AA04Q36145570-FC68267C-2764-4904-8AF2-BE30616C2812Q36157989-8007AAEE-1F8F-40D8-81F1-539A0C46C5C0Q36752080-EC009927-5E27-4965-842A-7D601D180BEBQ37190549-1C168102-A96F-48EC-AD85-8A0836F878DCQ37295956-B229AB6C-6244-453E-98A3-A881D93E267FQ38892032-9B6EF036-9F4F-4691-A21C-00565162A5EBQ38912494-64AAE56E-8B51-435D-9597-4F36A79ADEC5Q39218829-94F05BEC-3B28-405F-B754-533CD9B39389Q39396442-0AC9C085-F483-43CA-A045-FEF07B375944Q42367241-C6109B70-3FEF-4A87-AD07-C97362AE090CQ47161008-916E02C5-021D-49C6-BB12-0A168CA33709Q53631363-8E978ADC-58A7-46F8-B8E0-E93F2F7AFD34Q53810145-AB7A4B81-0ED3-46CB-A4EB-C8D1C0849D90Q59124952-5C64E9E4-F25F-4EE1-93AF-0B908D7EC83E
P2860
Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Randomised clinical trial: rel ...... ro-oesophageal reflux disease.
@en
Randomised clinical trial: rel ...... ro-oesophageal reflux disease.
@nl
type
label
Randomised clinical trial: rel ...... ro-oesophageal reflux disease.
@en
Randomised clinical trial: rel ...... ro-oesophageal reflux disease.
@nl
prefLabel
Randomised clinical trial: rel ...... ro-oesophageal reflux disease.
@en
Randomised clinical trial: rel ...... ro-oesophageal reflux disease.
@nl
P2093
P2860
P356
P1476
Randomised clinical trial: rel ...... ro-oesophageal reflux disease.
@en
P2093
P2860
P304
P356
10.1111/APT.12640
P407
P577
2014-01-28T00:00:00Z